Clover Health Investments, Corp.

NasdaqGS:CLOV Stock Report

Market Cap: US$309.6m

Clover Health Investments Balance Sheet Health

Financial Health criteria checks 6/6

Clover Health Investments has a total shareholder equity of $286.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $570.7M and $284.3M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$242.69m
EquityUS$286.39m
Total liabilitiesUS$284.28m
Total assetsUS$570.67m

Recent financial health updates

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Recent updates

Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Mar 16
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year

Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Mar 06
Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?

Clover Health: Its Luck May Have Ran Out

Feb 26

Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

Nov 21
Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation

We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Jul 07
We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely

Chamath Palihapitiya-linked Clover Health Investments trading near all-time low

Oct 14

Chamath Palihapitiya cuts stake in Clover Health to under 5%

Oct 04

Rethinking My Clover Health Position

Sep 12

Clover Paid The Price Of Its Alleged Lies; Time To Move On

Aug 17

Clover Health Investments to name president Andrew Toy as CEO

Aug 08

Clover Health Is A Buy Ahead Of Earnings

Jul 29

Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2

Jul 15

Is Clover Health A Good Healthcare Sector Stock Pick?

Jun 30

Clover Set To Report Earnings Tonight: Levels To Watch

May 09

Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week

Mar 04
Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week

Good News From Clover Health

Feb 25

Clover Health Is Now Undervalued, But Gains Not Guaranteed

Jan 24

Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out

Dec 03

Why Clover Health Investments (NASDAQ:CLOV) has Time to Develop a Superior Product

Oct 21
Why Clover Health Investments (NASDAQ:CLOV) has Time to Develop a Superior Product

Clover Health: Dilution Fears

Sep 24

Clover Health: The Product Is Good, The Balance Sheet Is Not

Sep 02

Clover Health Investments, Corp. (NASDAQ:CLOV) Lacks Institutional Ownership, but has High Growth and Co-Founders with Skin in the Game

Aug 26
Clover Health Investments, Corp. (NASDAQ:CLOV) Lacks Institutional Ownership, but has High Growth and Co-Founders with Skin in the Game

Financial Position Analysis

Short Term Liabilities: CLOV's short term assets ($428.0M) exceed its short term liabilities ($261.1M).

Long Term Liabilities: CLOV's short term assets ($428.0M) exceed its long term liabilities ($23.2M).


Debt to Equity History and Analysis

Debt Level: CLOV is debt free.

Reducing Debt: CLOV currently has no debt however we can't compare to 5 years ago as we have no data for that period.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CLOV has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: CLOV has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 6.6% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.